...
首页> 外文期刊>Schizophrenia research >Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
【24h】

Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.

机译:精神分裂症中水泡谷氨酸转运蛋白1和复合蛋白II mRNA的表达降低:进一步证据表明影响谷氨酸神经元的突触病理。

获取原文
获取原文并翻译 | 示例
           

摘要

Synaptic protein gene expression is altered in schizophrenia. In the hippocampal formation there may be particular involvement of glutamatergic neurons and their synapses, but overall the profile remains unclear. In this in situ hybridization histochemistry (ISHH) study, we examined four informative synaptic protein transcripts: vesicular glutamate transporter (VGLUT) 1, VGLUT2, complexin I, and complexin II, in dorsolateral prefrontal cortex (DPFC), superior temporal cortex (STC), and hippocampal formation, in 13 subjects with schizophrenia and 18 controls. In these areas, VGLUT1 and complexin II are expressed primarily by excitatory neurons, whereas complexin I is mainly expressed by inhibitory neurons. In schizophrenia, VGLUT1 mRNA was decreased in hippocampal formation and DPFC, complexin II mRNA was reduced in DPFC and STC, and complexin I mRNA decreased in STC. Hippocampal VGLUT1 mRNA declined with age selectively in the schizophrenia group. VGLUT2 mRNA was not quantifiable due to its low level. The data provide additional evidence for a synaptic pathology in schizophrenia, in terms of a reduced expression of three synaptic protein genes. In the hippocampus, the loss of VGLUT1 mRNA supports data indicating that glutamatergic presynaptic deficits are prominent, whereas the pattern of results in temporal and frontal cortex suggests broadly similar changes may affect inhibitory and excitatory neurons. The impairment of synaptic transmission implied by the synaptic protein reductions may contribute to the dysfunction of cortical neural circuits that characterises the disorder.
机译:精神分裂症中突触蛋白基因表达发生改变。在海马结构中,可能特别牵涉谷氨酸能神经元及其突触,但总体上仍不清楚。在这项原位杂交组织化学(ISHH)研究中,我们检查了背侧前额叶皮层(DPFC),上颞叶皮层(STC)中的四个信息性突触蛋白转录物:囊泡谷氨酸转运蛋白(VGLUT)1,VGLUT2,complexin I和complexin II。和精神分裂症的13名受试者和18名对照的海马体形成。在这些区域,VGLUT1和complexin II主要由兴奋性神经元表达,而complexin I主要由抑制性神经元表达。在精神分裂症中,海马形成和DPFC中的VGLUT1 mRNA降低,DPFC和STC中的complexin II mRNA降低,而STC中的complexin I mRNA降低。精神分裂症组海马VGLUT1 mRNA随年龄选择性下降。 VGLUT2 mRNA水平低,因此无法定量。根据三个突触蛋白基因表达的减少,这些数据为精神分裂症的突触病理提供了额外的证据。在海马中,VGLUT1 mRNA的丢失支持了表明谷氨酸能突触前缺陷突出的数据,而颞叶和额叶皮质的结果模式表明,大致相似的变化可能影响抑制性和兴奋性神经元。突触蛋白减少所暗示的突触传递障碍可能导致表征该疾病的皮质神经回路功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号